ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 17.15
+1.15 (7.19%)
At close: Nov 28, 2025
ViroGates Market Cap
ViroGates has a market cap or net worth of 132.65 million as of November 28, 2025. Its market cap has increased by 129.96% in one year.
Market Cap
132.65M
Enterprise Value
128.31M
Revenue
8.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.15
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 132.65M, a decrease of -48.83%. That is a compound annual growth rate of -8.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 132.65M | 61.79% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | 254.51M | 144.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.38T |
| Coloplast | 130.89B |
| Genmab | 125.11B |
| ALK-Abelló | 51.05B |
| Demant | 46.65B |
| H. Lundbeck | 41.87B |
| Zealand Pharma | 36.94B |
| Ambu A/S | 23.27B |